WTA Mandates SRY Gene Testing for Women’s Tennis Eligibility

The Women’s Tennis Association (WTA) has introduced a new policy requiring players to undergo a one-time genetic test to confirm their eligibility to compete in the women’s category. This move positions the WTA alongside other major sports governing bodies that are implementing genetic screening to ensure fair competition.

SRY Gene Testing Explained

Under the updated WTA women’s eligibility policy, athletes will be screened for the presence of the SRY gene. This gene, located on the Y chromosome, plays a crucial role in male-typical sex development. The testing process is straightforward